# Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock

Study · id `cardio:ct-nct03813134` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03813134](<https://clinicaltrials.gov/study/NCT03813134>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03813134

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 428 participants.

## Technical summary

Registry record NCT03813134. Randomized; no masking; primary purpose treatment. Start 2019-10-11 (actual); primary completion 2023-03-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 428 participants (planned count; ClinicalTrials.gov record NCT03813134, source copy `cardio:ctgov-nct03813134-2021-05-03`, retrieved 2026-10-31)
- Started: 2019-10-11 (actual) (ClinicalTrials.gov record NCT03813134, source copy `cardio:ctgov-nct03813134-2021-05-03`, retrieved 2026-10-31)
- Primary completion: 2023-03-03 (anticipated) (ClinicalTrials.gov record NCT03813134, source copy `cardio:ctgov-nct03813134-2021-05-03`, retrieved 2026-10-31)
- Completion: 2024-02-01 (anticipated) (ClinicalTrials.gov record NCT03813134, source copy `cardio:ctgov-nct03813134-2021-05-03`, retrieved 2026-10-31)
- Countries: Austria; Belgium; Germany; Italy; Latvia; Norway; Spain; United Kingdom (ClinicalTrials.gov record NCT03813134, source copy `cardio:ctgov-nct03813134-2021-05-03`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03813134-2021-05-03`, retrieved 2026-10-31)

## The registry's words

- Brief title: Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock
- Acronym: EUROSHOCK
- Condition: Cardiogenic Shock
- Intervention (Procedure): Percutaneous coronary intervention (PCI)
- Intervention (Other): Pharmacological Support
- Intervention (Device): VA-ECMO
- Lead sponsor: University of Leicester
- Lead sponsor class: OTHER
- Collaborator: European Commission
- Collaborator class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER
- Collaborator: KU Leuven
- Collaborator class: OTHER
- Collaborator: University of East Anglia
- Collaborator class: OTHER
- Collaborator: Deutsches Herzzentrum Muenchen
- Collaborator class: OTHER
- Collaborator: A.O. Ospedale Papa Giovanni XXIII
- Collaborator class: OTHER
- Collaborator: Chalice Medical Ltd
- Collaborator class: UNKNOWN
- Collaborator: Ludwig-Maximilians - University of Munich
- Collaborator class: OTHER
- Collaborator: University of Tromso
- Collaborator class: OTHER
- Collaborator: Institut d'Investigacions Biomèdiques August Pi i Sunyer
- Collaborator class: OTHER
- Collaborator: Paula Stradina Liniska Universitates
- Collaborator class: UNKNOWN
- Collaborator: Accelopment AG
- Collaborator class: OTHER
- Collaborator: Universiteit Antwerpen
- Collaborator class: OTHER
- Collaborator: European Cardiovascular Research Center
- Collaborator class: NETWORK

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Cardiogenic shock (`cardio:cardiogenic-shock`)
- Registry lists this organization as a collaborator: European Commission (`cardio:org-european-commission`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)
- Registry lists this organization as a collaborator: KU Leuven (`cardio:org-ku-leuven`)
- Registry lists this organization as a collaborator: University of East Anglia (`cardio:org-university-of-east-anglia`)
- Registry lists this organization as a collaborator: Deutsches Herzzentrum Muenchen (`cardio:org-deutsches-herzzentrum-muenchen`)
- Registry lists this organization as a collaborator: Ludwig-Maximilians - University of Munich (`cardio:org-ludwig-maximilians-university-of-munich`)
- Registry lists this organization as a collaborator: Universiteit Antwerpen (`cardio:org-universiteit-antwerpen`)
- Registry lists this organization as a collaborator: European Cardiovascular Research Center (`cardio:org-european-cardiovascular-research-center`)

## Provenance

Content hash: 91f85eddb0982fc8d4e9f9b4f7d30b1749f3ec120b3a8679816b8898eba160bb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
